SEC Form 4 · accession 0002012524-26-000008
Theravance Biopharma, Inc. · TBPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Aine Miller
Officer — SVP, DEV & HEAD OF IRE OFFICE
Period of report
Aug 20, 2026
Accepted (ET)
Aug 24, 2026 · 6:04 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001583107
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Aug 20, 2026 | F | 6,258 | $16.95 | D | 189,826 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.